NanoBio Presentation Schedule
2008 ICAAC / IDSA
Oral V-3771
Tuesday, 10/28
9:00-9:15
Rm. 145
Poster
G-1194
A Novel Nanoemulsion Adjuvant Enhancing the Immune Response to β-propiolactone Inactivated Influenza Virus Using a Nasal Route in Ferrets
Sunday, 10/26
11:15 - 12:15
Hall C
A-1898
Novel Nanoemulsion NB-001 Permeates Skin by the Follicular Route
Monday, 10/27
M-2134
M-2135
Mechanism of Skin Penetration and Distribution of a Novel Nanoemulsion
V-3539
Safety, Tolerability and Pharmacokinetics of NB-001 in a Phase 2 Dose Ranging Trial in Subjects with Recurrent Herpes Labialis
12:15 - 1:15
V-3538
NB-001, A Novel Nanoemulsion Active Against Acyclovir (ACV) and Foscarnet (FOS)-Resistant Herpes Simplex Virus (HSV) 1 and 2
F1-3944
Novel Nanoemulsion Antimicrobials Tested Against Nine Gram-Positive Species
F1-3945
Antimicrobial Activity of Nanoemulsions Tested Against Seven Gram-Negative Speicies
Booth
# 408
An Adobe PFD file for each of the presentations is linked to its title above.
Company | Platform Technology | Dermatology | Anti-infectives | Vaccines | Careers | News
© NanoBio® Corporation 2010 NanoBio is a registered trademark of NanoBio Corporation. All other company, brand, and product names are or may be trademarks of their respective holders. Website by Mellon & Associates, LLC.